Viewing Expert Paul Harris, CFA | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Viewing Expert

Paul Harris, CFA , Portfolio Manager and Partner

Avenue Investment Management


Date Signal Chart Symbol Company Opinion Price
2017-01-16 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Market. Because Trump won both houses of Congress, and there was a sense he was going to bring down tax rates, get rid of a lot of red tape, temper Dodd-Frank a little, we need to actually see things getting done and what is on the agenda. There will be some volatility in the market, and you want to Buy the volatility. If he can accomplish even half what he has talked about, it would bode well for the stock market. When you have an opportunity like this, if you like a particular stock and the fundamentals and a particular sector, now would be the time to get in. However, you have to feel comfortable with what you are buying.


Price:
$0.020
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
_N/A
2017-01-16 TOP PICK Must be logged in to use chart ACQ-T AutoCanada Inc.

This fell apart over several years, simply because they were in BC and Alberta during the hard time. Secondly it is supposed to be a growth by acquisition story and they were buying 2-3 dealerships a year, but 1 year they did 15 dealerships, way too many. Also, they didn’t really integrate their back-office effectively. New management came in and are committed to making only 2-3 acquisitions a year. A good story at these levels, and it should continue to do well. Dividend yield of 1.55%. (Analysts’ price target is $24.25.)


Price:
$25.750
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 COMMENT Must be logged in to use chart AMZN-Q Amazon.com

An incredible story, but from a valuation perspective it is incredibly expensive. They dominate online retail spending and no one is coming close. The big box stores are having a really hard time competing on an online basis. The money coming from Amazon’s cloud business AWS is really subsidizing the retail side of it.


Price:
$817.140
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
No
2017-01-16 BUY on WEAKNESS Must be logged in to use chart ATD.B-T Alimentation Couche-Tard (B)

Growth by acquisition, and have done a very good job over the years of taking over places, reinventing them, etc. Expects there is good growth, especially in the US. Possibly looking at growing in the UK and Ireland. Dominating the convenience store business. Still a lot more room in the US to do that. Acquisitions have to be bigger to make a difference to them, but when they make an acquisition, the stock will probably pull back and that’s when you need to be a buyer. They are very good at integrating acquisitions, bringing down their costs and making the supply chain really work to their benefit. Trading at 17X next year’s earnings, so it is not expensive.


Price:
$61.300
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Unknown
2017-01-16 COMMENT Must be logged in to use chart BA-N Boeing

This industry is doing very well and they have the winds to their back. Coming out with new products. There has been good reception to the new wide-body planes, which is really helping out a lot of companies. There is certainly potential for this to go higher. They will probably benefit from better global growth, which he expects to see in the next several years.


Price:
$158.830
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Unknown
2017-01-16 PAST TOP PICK Must be logged in to use chart BAC-N Bank of America

(A Top Pick Feb 11/16. Up 109.35%.) This has done incredibly well since November 9. It is still trading at .8X Book. (Canadian banks are trading at close to 2X Book.) It has a great franchise, whether it is retail or investment banking. He can see a lot of room on the upside. Try to Buy on weakness.


Price:
$23.010
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 COMMENT Must be logged in to use chart BAM.A-T Brookfield Asset Management (A)

A holding company for many other Brookfield holdings, including real estate. A really well run company. They’ve really narrowed NAV, because it used to trade at a discount. They spin out stuff and you end up getting 1 or 2 shares. An asset management company, so they constantly buy assets. They look for undervalued assets, nurture them and grow them and then either spin them out or sell them. This is always going to trade at a discount to its NAV.


Price:
$44.530
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
No
2017-01-16 PAST TOP PICK Must be logged in to use chart BMW-GR Bayerische Motoren Werke AG

(A Top Pick Feb 11/16. Up 34.39%.) About 40% of this is owned by a German family, so it has a very stable ownership base. Also, it has a great brand. They’ve done a very good job on research/development.


Price:
$0.000
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 TOP PICK Must be logged in to use chart BX-N Blackstone Group LP

The largest private equity firm globally. Trading at 10X earnings. The stock really didn’t move when all the other financials did. They have about $100 billion that they can spend to buy things if things go bad. They were really good buyers of assets all the way from 2008-2009. Have some great assets which have matured and is now time to sell, but they need a strong equity market. When they get this in the next couple of years, they will harvest a lot from the purchases they made. Not expensive. Dividend yield of 5.45%. (Analysts’ price target is $33.83.)


Price:
$30.090
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 HOLD Must be logged in to use chart CNR-T Canadian National R.R.

Sell? Transports have done quite well in the last while and are up a fair bit. This is trading at about 18X earnings. The rail industry has consolidated quite heavily over the last 5-10 years, so you have seen them really thinking about ROI. Because they have a better efficiency and asset utilization, they’ve had better margins, and that is going to continue. With oil stabilizing and commodities doing a little better, you should see better returns over the next while.


Price:
$93.370
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 BUY on WEAKNESS Must be logged in to use chart ENB-T Enbridge

TransCanada (TRP-T) or Enbridge (ENB-T) for a 10-year hold? Both companies have done something very interesting by making big US acquisitions. He likes this one because there is some very good growth and management has been spectacular.


Price:
$57.270
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 COMMENT Must be logged in to use chart FB-Q Facebook

From a valuation perspective, this is not a stock he would own as the metrics are too high for him. When you talk to advertising and Digital media people, and ask where the advertising dollar is going, it is really just going to 2 places; Google and Facebook. They really have a stranglehold on Internet advertising. As print media disappears, it is all going to these 2 companies. They have some real momentum behind them in growing their businesses. The risk from a valuation perspective is if people start seeing this as a media company as opposed to a tech company.


Price:
$128.340
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
No
2017-01-16 PAST TOP PICK Must be logged in to use chart FSV-T Firstservice Corp

(A Top Pick Feb 11/16. Up 32.48%.) A real estate management company, but also do a lot of other things. They have a large business in the US. Also, have a lot of branded businesses like California Closets, College Pro Painting, etc. Still a fragmented industry, and a lot of it is still “mom and pop”, so every year they make bolt-on acquisitions, so have done a very good job of slowly growing their business. Not a cheap stock, so you have to be careful getting into it. Buy it on weakness.


Price:
$64.040
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 TOP PICK Must be logged in to use chart GILD-Q Gilead Sciences Inc.

This has 2 big drugs; Hepatitis C and HIV. The HIV drug is doing very well and continues to grow. The problem with the Hep C drug is that it cures, so revenue is coming down and the market is implying that the decline in revenue is going to be a lot faster. Secondly, the market is giving them no value for their existing HIV drug which continues to do well. They are also not getting any value from the fact that there are still a lot of people with hepatitis C, and they’ll need to use the drug. Zero value is being given to the pipeline even though they have some good products. A fantastic balance sheet with no debt. They have a lot of cash overseas, and if they are allowed to bring this back, there will be benefits. Trading at 7X earnings. Yield of 2.57%. (Analysts’ price target is $94.89.)


Price:
$73.070
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
Yes
2017-01-16 COMMENT Must be logged in to use chart MFC-T Manulife Financial

Manulife (MFC-T) or Sun Life (SLF-T)? As interest rates started going up, they have done well in the last little while. To him, Sun Life is a much more stable company. This company has a really great Asian franchise which can drive their business a lot more than Sun Life’s.


Price:
$24.300
Subject:
GLOBAL LARGE
Bias:
UNKNOWN
Owned:
No
Showing 1 to 15 of 2,310 entries
<< < 1 2 3 4 5 > >>

No Comments.


You must be logged in to comment.